METIS
Pivotal, Open-Label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) (150kHz) for 1-10 Brain Metastases From Non-Small Cell Lung Cancer (NSCLC)
More Information
NRG BN007
A Randomized Phase II/III Open Label Study of Ipilimumab and Nivolumab Versus Temeozolomide in Patients With Newly Diagnosed MGMT (Tumor o-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
More Information
